Approval · Notice of Compliance 9647 · 2008
CALCIJEX: Notice of Compliance 9647
Issued July 2, 2008
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9647
- Date
- July 2, 2008
- Company
- Abbott Laboratories Co.Saint-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update to the new product monograph format
- Therapeutic class
- Vitamin D3 metabolite
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CALCIJEX | Not yet assigned | — |
Medicinal ingredients
- CALCITRIOL 1 MCG per ML
- CALCITRIOL 2 MCG per ML